Support Alert

Drug Safety Update: montelukast (Singulair) - reminder of the risk of neuropsychiatric reactions

The Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update highlights new and updated advice.

Loading...

Renew for 2022

Your dedication to patient care has made us proud during 2021.

That's why you can count on us to represent your interests and support your efforts every step of the way in 2022.

RENEW YOUR MEMBERSHIP TODAY